Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.6500
-0.0250 (-3.70%)
At close: Feb 4, 2026
Genetic Analysis AS Revenue
Genetic Analysis AS had revenue of 3.18M NOK in the quarter ending September 30, 2025, a decrease of -12.24%. This brings the company's revenue in the last twelve months to 21.68M, up 9.98% year-over-year. In the year 2024, Genetic Analysis AS had annual revenue of 20.68M, down -10.71%.
Revenue (ttm)
21.68M NOK
Revenue Growth
+9.98%
P/S Ratio
2.04
Revenue / Employee
1.35M NOK
Employees
16
Market Cap
41.67M SEK
Revenue Chart
* This company reports financials in NOK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20.68M | -2.48M | -10.71% |
| Dec 31, 2023 | 23.16M | 2.42M | 11.65% |
| Dec 31, 2022 | 20.75M | 7.37M | 55.08% |
| Dec 31, 2021 | 13.38M | 5.84M | 77.51% |
| Dec 31, 2020 | 7.54M | -3.52M | -31.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lightning Group AB | 59.11M |
| QBNK Holding AB | 41.12M |
| Redsense Medical AB | 31.84M |
| Touchtech AB | 22.85M |
| Vidhance AB | 22.67M |
| Tessin Nordic Holding AB | 13.35M |
| Biofrigas Sweden AB | 4.10M |
| Smoltek Nanotech Holding AB | 3.50M |